Drug Delivery | |
Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway | |
Aseem Bhatnagar1  Javed Ali2  Sanjula Baboota2  Abdulmohsen H. Alrohaimi3  Gulam Mustafa3  Alka Ahuja4  | |
[1] Department of Nuclear Medicine Division (NMD), Institute of Nuclear Medicine & Allied Sciences, Timarpur, Timarpur, Delhi, India, an;Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India;Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India;College of pharmacy, Al-Dawadmi Campus, Shaqra University, Riyadh, Kingdom of Saudi Arabia;Department of Pharmacy, Oman Medical College, Azaiba, Muscat, Sultanate of Oma; | |
关键词: Brain targeting; gamma scintigraphy; intranasal drug delivery; neural pathway; non-neural pathway; olfactory nerve; ropinirole; trigeminal nerve; | |
DOI : 10.3109/10717544.2014.923064 | |
来源: publisher | |
【 摘 要 】
The effectiveness of intranasal drug delivery for brain targeting has emerged as a hope of remedy for various CNS disorders. The nose to brain absorption of therapeutic molecules claims two effective pathways, which include trans-neuronal for immediate action and para-neuronal for delayed action. To evaluate the contribution of both the pathways in absorption of therapeutic molecules and nanocarriers, lidocaine, a nerve-blocking agent, was used to impair the action potential of olfactory nerve. An anti-Parkinson drug ropinirole was covalently complexes with 99mTc in presence of SnCl2 using in-house developed reduction technology. The radiolabeled formulations were administered intranasally in lidocaine challenged rabbit and rat. The qualitative and quantitative outcomes of neural and non-neural pathways were estimated using gamma scintigraphy and UHPLC-MS/MS, respectively. The results showed a significant (p ≤ 0.005) increase in radioactivity counts and drug concentration in the brain of rabbit and rat compared to the animal groups challenged with lidocaine. This concludes the significant contribution (p ≤ 0.005) of trans-neuronal and para-neuronal pathway in nose to brain drug delivery. Therefore, results proved that it is an art of a formulator scientist to make the drug carriers to exploit the choice of absorption pathway for their instant and extent of action.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202004239049939ZK.pdf | 445KB | download |